CompletedPhase 4NCT05714865
Implementing LISA Surfactant in Nigeria
Studying Neonatal acute respiratory distress syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Indiana University
- Principal Investigator
- Osayame A Ekhaguere, MBBS, MPHIndiana University School of Medicine
- Intervention
- Surfactant(drug)
- Enrollment
- 349 target
- Eligibility
- All sexes
- Timeline
- 2023 – 2025
Study locations (6)
- Federal Medical Center Asaba, Asaba, Delta, Nigeria
- University of Benin Teaching Hospital, Benin City, Edo, Nigeria
- National Hospital Abuja, Garki, FCT Abuja, Nigeria
- Aminu Kano Teaching Hospital, Zaria, Kano State, Nigeria
- Lagos University Teaching Hospital., Idi Araba, Lagos, Nigeria
- University of Nigeria Teaching Hospital, Enugu, Nigeria
Collaborators
BLES Biochemicals Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05714865 on ClinicalTrials.govOther trials for Neonatal acute respiratory distress syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07437391Effect of L-Carnitine Supplementation in Preterm NeonatesMuhammad Aamir Latif
- RECRUITINGNCT07154134Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress SyndromeTanta University
- RECRUITINGNCT06874478Respiratory Distress and Elective Cesarean Section at TermAssiut University
- RECRUITINGPHASE4NCT06074380Non Inferiority Trial Investigating Surfactants Administered Via MISTEndeavor Health
- RECRUITINGNCT06031324The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory DistressBursa City Hospital
See all trials for Neonatal acute respiratory distress syndrome →